Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit Disorder with Hyperactivity

Explore clinical trials studying Attention Deficit Disorder with Hyperactivity. Study availability and eligibility vary by location and protocol.

1,408 public trials 160 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit Disorder with Hyperactivity trial results

Completed

Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder

NCT00877487

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Valley Clinical Research, Inc. El Centro, California, United States
  • Peninsula Research Associates, Inc Rolling Hills Estates, California, United States
  • PCSD Feighner Research San Diego, California, United States
View all 55 locations
View Trial Details
Completed

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD

NCT03247517

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Neuropsychiatric Research Center of Orange County Orange, California, United States
  • Indago Research & Health Center, Inc. Hialeah, Florida, United States
  • Clinical Neuroscience Solutions, Inc Jacksonville, Florida, United States
View Trial Details
Completed

Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe

NCT01500694

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Medizinische Universitat Graz Univ fur Kinder Graz, Austria
  • Institut fur Psychosomatik Vienna, Austria
  • Universitaire Kinder-end Jeugdpsychatrie Hoboken, Belgium
  • Centre de Reference Neuropediatrique Multidisciplinaire Namur, Belgium
View all 60 locations
View Trial Details
Completed

Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00735371

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Valley Clinical Research, Inc. El Centro, California, United States
  • Peninsula Research Associates, Inc Rolling Hills Estates, California, United States
  • Psychiatric Centers at San Diego (PCSD-Feighner Research Institute) San Diego, California, United States
View all 45 locations
View Trial Details
Completed

Efficacy and Safety of SPD503 in Combination With Psychostimulants

NCT00734578

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Melmed Center Scottsdale, Arizona, United States
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Valley Clinical Research, Inc. El Centro, California, United States
View all 61 locations
View Trial Details
Completed

A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)

NCT00500149

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Univ. of CA, Irvine Child Development Center Irvine, California, United States
  • Shire Clinical Research Site Wildomar, California, United States
  • Vince and Associates Clinical Research Overland Park, Kansas, United States
View Trial Details
Completed

SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms

NCT00367835

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • HOPE Research Institute Phoenix, Arizona, United States
  • Valley Clinical Research El Centro, California, United States
  • Peninsula Research Associates Inc Rolling Hills Estates, California, United States
  • Sarkis Clinical Trials Gainesville, Florida, United States
View all 34 locations
View Trial Details
Completed

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

NCT01081145

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Psychiatric Centers at San Diego, Feighner Research San Diego, California, United States
  • Encompass Clinical Research - North Coast Spring Valley, California, United States
View all 81 locations
View Trial Details

Related conditions